MedTrace Logo

Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.

NCT01260389 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 734

Last updated 2021-07-13

No results posted yet for this study

Summary

This study would like to test the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in Chronic Obstructive Pulmonary Disease (COPD) patients over a 3 month-period.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

BEHAVIORAL

pharmaceutical care intervention

Pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD).

Sponsors & Collaborators

  • University Ghent

    collaborator OTHER

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Guy Brusselle, M.D., Ph.D. · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-05-31
Completion
2011-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01260389 on ClinicalTrials.gov